Connect with us

News

How femtech is helping fibromyalgia patients

Published

on

Fibromyalgia is a poorly understood condition causing chronic, widespread pain in sufferers – the majority of which are women.

According to the NHS, the condition affects around seven times more women than men, and typically starts between the ages of 30 and 50, although it can affect any age.

It is not known what causes it, although theories suggest its onset often coincides with periods of stress, such as bereavement, injury or giving birth. There is also thought to be a hereditary aspect too.

The main symptom is generalised pain, which may be accompanied by extreme tiredness, muscle stiffness, difficulty sleeping and problems with memory and concentration, which is known as fibro-fog.

There is no cure for fibromyalgia, rather a number of ways of treating the symptoms, including anti-depressants, painkillers and lifestyle changes.

However, with advances in technology that focuses on female-specific conditions, known as femtech, could there be more solutions on the horizon?

Digital pain relief

Pain is often the most debilitating symptom of fibromyalgia, and, understandably, many women don’t want to be wholly reliant on painkillers, which can themselves bring unwanted side effects.

A number of developments in the femtech world have led to the creation of digital solutions, such as NeuroMetrix’s Quell device, which was last year granted breakthrough device designation by the US Food and Drug Administration (FDA) to treat the symptoms of fibromyalgia in adults.

The device uses transcutaneous electrical nerve stimulator (TENS) technology to offer symptomatic relief and management of chronic pain in the lower extremities.

Designed for over-the-counter use, Quell is a non-invasive, wearable device which is enabled by a tailored microchip that offers flexible, accurate nerve stimulation at increased power, providing targeted pain relief without the need for drugs.

Digital therapy

Another treatment that is often offered to fibromyalgia patients alongside medication is some form of talking therapy, but these can be inconvenient to access and attend.

Another technology that received Breakthrough Device Designation from the FDA last year is Swing Therapeutics’ programme of digital therapy.

It offers simple-to-use, daily digital therapeutic lessons and interactive exercises to help patients apply well-established principles to their own specific circumstances and symptoms, giving them the tools to manage their condition.

The self-guided program is designed to foster patients’ understanding and acceptance of their symptoms, while teaching powerful condition management skills via acceptance and commitment therapy (ACT). The program, which is currently being researched and trialled, also incorporates a tool to help users manage their symptom flare-ups – a common occurrence with fibromyalgia.

Symptom trackers

While not designed to cure or manage pain, symptom trackers can help fibromyalgia sufferers by noticing their triggers or any patterns to their flare-ups.

Taking a more careful note of how the condition affects them can help patients learn how best to manage the condition, minimising the pain and the disruption.

There are a variety of symptom tracking apps on the market, including Manage My Pain and PainScale, and all work in a broadly similar way.

While not specifically for fibromyalgia, PainScale, which was created with advice from doctors and chronic pain patients, tracks and organises all symptoms.

It also provides personalised pain management education, with more than 800 articles, health tips, exercises, and information about a whole range of programmes and treatment options. It can also be used to log and track pain so patients can identify triggers, helping them manage their condition.

Similarly, Manage My Pain helps patients keep detailed notes on their symptoms, which not only put them in more control of the condition, but can also help when seeking medical advice or treatment.

Conclusive proof

Because fibromyalgia is so widely misunderstood and under-researched, with vague if debilitating symptoms, there has traditionally been a tendency to dismiss it – especially bearing in mind long-standing issues with medical practitioners dismissing women’s pain.

However, in recent years, AI (artificial intelligence) and machine learning have been used to prove the condition exists – and may have a neurological cause.

In 2017, researchers used machine learning to distinguish the brain scans of those with fibromyalgia from those without, and had 93 per cent accuracy.

In the study, MRI machines were used to capture images of the brain signals of 37 fibromyalgia patients and 35 healthy people as a control. All participants had pressure applied to their right thumbnail to cause “severe but tolerable pain,” explained the researchers in their paper, which was published in the journal Pain.

Those with fibromyalgia were seen on the MRI to experience more pain than the healthy controls, according to a neurological marker of physical pain, as well as showing different activity in the insula area of the brain, related to sensory integration, and the medial prefrontal cortex, which is important for emotional regulation.

These different neurological responses created a brain signature for fibromyalgia patients, which a machine-learning algorithm was then able to use to predict which brain scans showed fibromyalgia and which did not.

While the research did not attempt to study the cause of the pain, for many fibromyalgia sufferers, simply knowing that it was real was cause for relief.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Only one-in-three voters say US healthcare system meeting women’s needs

Published

on

Only 31 per cent of US voters believe healthcare does a good job of meeting women’s needs, according to a national survey.

The survey found broad agreement that women have distinct health needs requiring specific attention, but that care falls short at several stages of life.

Impact Research and Echelon Insights conducted the survey for Center Forward among 1,206 registered voters in the likely electorate across the US.

Tara Evans, marketing director for Plan B One-Step, said: “These findings should serve as a wake-up call for the health care industry and for policymakers.

“Women are telling us loudly and clearly that the system is not working for them. From reproductive health to menopause care to postpartum support, the gaps are real, they are significant, and voters want action.”

Only 31 per cent of respondents said the healthcare system did a good or very good job of meeting women’s health needs.

This compared with 41 per cent who said it performed well in meeting men’s health needs.

Half of the women surveyed said the system did not pay enough attention to their health issues.

Some 41 per cent rated the system as poor or very poor at meeting women’s needs immediately before, during and after menopause.

A further 38 per cent gave the same rating for care following pregnancy and during the postpartum period.

The figure was 35 per cent for care provided while women were seeking to prevent pregnancy.

Overall, 92 per cent agreed that women have distinct health needs deserving specific attention, including 89 per cent of Republicans and 95 per cent of Democrats.

Access to screening for cancers affecting women was considered very important for policymakers to address by 81 per cent of respondents.

Prenatal care was prioritised by 78 per cent, while 77 per cent highlighted both gynaecological care and cardiovascular services.

Postpartum care was considered very important by 72 per cent, while 68 per cent said the same about diabetes and weight management services.

Some 46 per cent of voters said the healthcare system did a poor or very poor job of meeting the needs of rural patients.

Rural women were six percentage points more likely than voters overall to report difficulty accessing quality care.

The findings also showed that gaps in care were not evenly distributed.

Women who described their health as fair or poor were 15 percentage points more likely than those in excellent or very good health to say the system paid too little attention to their needs.

People earning less than US$50,000 a year were among those most likely to feel overlooked.

Among voters earning between US$30,000 and US$49,000 annually, 61 per cent said the system did not pay enough attention to their health issues.

Evans said: “The picture this data paints is one of a system that works better for some Americans than others, and women, particularly those with lower incomes or in rural communities, are bearing the greatest burden of that failure.

“Plan B is committed to being part of the solution by ensuring that at the very minimum, women have access to emergency contraception when they need it.”

Plan B One-Step is an over-the-counter emergency contraceptive available in all 50 US states without identification or a prescription.

The company says it donates up to 500,000 units each year to clinics, non-profit organisations, advocacy groups and other qualifying organisations supporting medically underserved communities.

The survey was conducted from 12 to 16 January 2026 and had a margin of sampling error of plus or minus 3.2 percentage points.

Plan B One-Step is a backup form of birth control intended to help prevent pregnancy after unprotected sex or when another contraceptive method fails.

It is not an abortion pill and does not affect implantation or harm an existing pregnancy.

Emergency contraception such as Plan B is used within 72 hours of unprotected sex and works better the sooner it is taken.

The findings form part of the 2026 Women’s Health Mandate, a five-part bipartisan series examining women’s healthcare in the US.

Continue Reading

Pregnancy

New reporting tool targets maternal-fetal teams as pregnancy complexity rises

Published

on

A new reporting tool built specifically for obstetrics and maternal-fetal medicine has launched, aimed at teams managing increasingly complex pregnancies with limited time and resources.

Trice Imaging has released Trice Workspace Reporting, which connects imaging, reporting and longitudinal patient data in a single workflow to support faster clinical decision making.

Birth rates are falling worldwide, but pregnancies are getting more complicated. Advanced maternal age, IVF-assisted pregnancies, rising obesity rates and a higher prevalence of hypertension and diabetes mean more cases now require specialist monitoring, advanced imaging and multidisciplinary care.

At the same time, clinical teams are stretched and facing growing administrative demands.

Trice Workspace Reporting brings together customisable reporting, dynamic pregnancy dating and longitudinal patient history with an AI-ready, EHR-interoperable infrastructure, all inside the company’s Tricefy image management platform.

The company says it aims to accelerate standardised and synchronised report turnaround, support timely clinical decisions and improve operational efficiency for fetal medicine services.

“Maternal fetal medicine teams are managing increasingly complex pregnancies while being asked to do more with limited time and resources,” said Mark A. Samii, chief revenue officer at Trice Imaging.

“Trice Workspace Reporting is designed to remove unnecessary friction from reporting by creating a structured digital foundation that supports today’s need for connected clinical workflows.

“It also provides a digital foundation as practices prepare for tomorrow and the evolution of AI-enabled fetal assessment, anomaly detection and outcome prediction technologies.”

Trice Imaging describes its mission as transforming the women’s health journey by connecting physicians, patients and healthcare systems. From independent practices to large hospital ecosystems, it aims to reach the entire women’s health continuum, spanning IVF and reproductive health, maternal-fetal medicine and OB/GYN, and onwards to lifelong women’s health.

For more than 17 years the firm has worked on cloud-based storage, retrieval, display, organisation and exchange of ultrasound medical images and associated information across health environments.

Its wider platform now extends to dynamic clinical reporting, AI-driven workflow optimisation, data analytics and secure patient engagement.

Trice Imaging holds regulatory and data protection clearances in 40 countries. It has offices in Miami and Stockholm, alongside a growing network of global distributors.

Continue Reading

News

Vespexx signs MOU with global femtech network Femtech Across Borders

Published

on

Vespexx, the femtech company behind couples preconception health platform Soonr, has signed a memorandum of understanding (MOU) with Femtech Across Borders, a global femtech network supporting women’s health initiatives across 80 countries.

The agreement was signed on June 30 at Korea Femtech Summit 2026, the first global femtech summit held in Korea, hosted by Vespexx.

Femtech Across Borders is a global femtech community led by founder Rachel Bartholomew, who entered the field after her own battle with cervical cancer.

The organisation connects women’s health innovators, companies, and institutions worldwide, supporting collaboration across borders.

“For Korean femtech to reach the world, connection with the global community matters more than anything,” said Scarlett Joowon Jung, co-CEO of Vespexx.

“Through our collaboration with Femtech Across Borders, we’ll continue to strengthen our role as a bridge between Korea and the global femtech community.”

Through the MOU, the two parties will work to lower the barriers between Korean and global femtech, raising awareness of women’s health, sharing networks, and exploring future opportunities to collaborate.

Vespexx, in particular, intends to serve as a bridge connecting Korean femtech companies with the global community, widening the path for domestic companies to reach international markets.

The agreement builds on Vespexx’s recent global momentum.

On June 30, the company hosted Korea Femtech Summit 2026, bringing together femtech leaders from Korea and abroad, and used the occasion to announce the launch of Femtech Korea, an industry network that brings Korean femtech companies together and connects them with the world.

The partnership with Femtech Across Borders extends that effort outward, linking Korea’s domestic network to the global community.

Learn more about Vespexx at vespexx.com

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.